Ramirez, G., Thompson, K., & White, D
The most recent studies demonstrate the advantage of sinus rhythm control and maintenance among HFpEF patients
It was August 2022, exactly when this drug was starting its social-media-fueled ascent as the latest weight loss miracle, one that so many people don't truly need, yet are dying to get their hands on
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, obesity
FIGURE 5 3.3.5 The comparison of effective rate between two groups As shown in the table below, significantly effective rate and effective rate in RG group respectively were 12 (24.5%) and 6 (12.2%)